1942 Journal of Natural Products, 2009, Vol. 72, No. 11
Murata et al.
215 (-10 600), 201 (-41 600) nm; 1H and 13C NMR, Table 1;
HRFABMS m/z 720.3368 [M + H]+ (calcd for C35H50N3O13, 720.3345).
were free of duplicated signals due to absence of the cis-trans
isomerization of the 10-N amide bonds. Compounds 9 and 11 lack
an acyl group on Glc-6 or an acylated glucosyl moiety, which was
observed in meehanine C1 and dracotanosides C and D.5 Com-
pounds 5-8, 10, and 12 are acyl analogues of the spermidine
alkaloids from M. urticifolia.
Meehanine N (3): colorless, amorphous powder; [R]23 -23.9 (c
D
0.36, MeOH); CD (c 0.036, MeOH) λ(θ) 243 (3500), 225 (-17 400),
1
210 (-7300), 201 (-29 100) nm; H and 13C NMR, Tables 1 and 2;
HRFABMS m/z 742.3782 [M + H]+ (calcd for C35H56N3O14, 742.3764).
Meehanine O (4): colorless, amorphous powder; [R]21 -16.7 (c
D
Although M. urticifolia is not utilized for folk medicine and is
not blended in Kampo formulas in Japan, new findings concerning
the biological activities of these constituents are expected.
0.18, MeOH); CD (c 0.018, MeOH) λ(θ) 242 (8200), 224 (-8000),
207 (-700), 201 (-15 600) nm; 1H and 13C NMR, Tables 1;
HRFABMS m/z 700.3657 [M + H]+ (calcd for C33H54N3O13, 700.3658).
Meehanine P (5): colorless, amorphous powder; [R]20D 1.4 (c 0.14,
MeOH); CD (c 0.028, MeOH) λ(θ) 263 (8600), 224 (-24 600), 204
Experimental Section
1
(29 300) nm; H and 13C NMR, Table 2; HRFABMS m/z 872.4181
[M + H]+ (calcd for C44H62N3O15, 872.4183).
General Experimental Procedures. Optical rotations were measured
on a JASCO P-2300 polarimeter. CD spectra were recorded on a
JASCO J-700 spectropolarimeter. 1H NMR (400 MHz) and 13C NMR
(100 MHz) spectra were recorded on a JEOL JNM-AL400 spectrometer,
and chemical shifts are given as δ values with TMS as internal standard
at 30 °C. Inverse-detected heteronuclear correlations were measured
using HMQC (optimized for 1JC-H ) 145 Hz) and HMBC (optimized
Meehanine Q (6): colorless, amorphous powder; [R]20D 1.9 (c 0.21,
MeOH); CD (c 0.018, MeOH) λ(θ) 261 (7400), 225 (-24 300), 204
1
(32 900) nm; H and 13C NMR, Table 2; HRFABMS m/z 872.4203
[M + H]+ (calcd for C44H62N3O15, 872.4183).
Meehanine R (7): colorless, amorphous powder; [R]21D -2.2 (c 0.46,
MeOH); CD (c 0.048, MeOH) λ(θ) 245 (5600), 224 (-24 400), 202
n
1
(33 400) nm; H and 13C NMR, Table 2; HRFABMS m/z 840.4490
for JC-H ) 8 Hz) pulse sequences with a pulsed field gradient.
[M + H]+ (calcd for C41H66N3O15, 840.4496).
HRFABMS data were obtained on a JEOL JMS700 mass spectrometer,
using a m-nitrobenzyl alcohol or glycerol matrix. Preparative LPLC
and HPLC were performed on a Jasco 2089 instrument and detected
by UV at 210 nm.
Meehanine S (8): colorless, amorphous powder; [R]23D -6.7 (c 0.06,
MeOH); CD (c 0.012, MeOH) λ(θ) 252 (15 100), 224 (-8700), 205
1
(25 800) nm; H and 13C NMR, Table 2; HRFABMS m/z 798.4011
[M + H]+ (calcd for C38H60N3O15, 798.4026).
Plant Material. M. urticifolia (760 g) was collected in July 2007
and in September 2008 (670 g) in Sendai, Japan. The plant was
identified by Dr. Koji Yonekura, Tohoku University, Sendai, Japan. A
voucher specimen was deposited at the herbarium of Tohoku Pharma-
ceutical University under No. 20070727.
Meehanine T (9): colorless, amorphous powder; [R]23 -21.7 (c
D
0.12, MeOH); CD (c 0.012, MeOH) λ(θ) 241 (10 600), 224 (-6700),
205 (14 300) nm; 1H and 13C NMR, Table 1; HRFABMS m/z 580.3229
[M + H]+ (calcd for C29H46N3O9, 580.3236).
Extraction and Isolation. The dried and powdered whole plants
(760 g) of M. urticifolia were extracted with MeOH (12 L) at room
temperature for a month. The MeOH extract was concentrated at
reduced pressure, suspended in H2O (1.5 L), and partitioned with Et2O
(3 × 1.0 L). The H2O layer (98.52 g) was passed through a porous
polymer gel column (Mitsubishi Diaion HP-20, 70-180 mm) and eluted
with H2O; 10%, 45%, and 90% MeOH; and MeOH. The 90% MeOH
eluate (5.5 g) was chromatographed on a reversed-phase column using
ODS (Cosmosil 140C18-OPN, Nacalai Tesque, 150 g) and was eluted
with 20%, 30%, 40%, 50%, 60%, and 80% MeOH (fractions 1A-1F).
Fractions 1E and 1F (259.1 mg) were subjected to preparative HPLC
[columns, Tosoh, ODS-100 V, 20-250 mm; solvent, MeCN-H2O (40:
60), and Kanto Chemical, Mightysil RP-18 GP, 10 × 250 mm; solvent,
MeCN-H2O (30:70) and MeOH-H2O (55:45)] to yield compounds 5
(1.4 mg), 6 (2.0 mg), and 7 (5.2 mg).
Meehanine U (10): colorless, amorphous powder; [R]23 -10.0 (c
D
0.04, MeOH); CD (c 0.008, MeOH) λ(θ) 250 (22 700), 225 (-13 000),
205 (38 700) nm; 1H and 13C NMR, Table 2; HRFABMS m/z 798.4031
[M + H]+ (calcd for C38H60N3O15, 798.4026).
Meehanine V (11): colorless, amorphous powder; [R]23 -12.0 (c
D
0.20, MeOH); CD (c 0.020, MeOH) λ(θ) 253 (8000), 223 (-35 400),
203 (27 200) nm; 1H and 13C NMR, Table 1; HRFABMS m/z 728.3600
[M + H]+ (calcd for C34H54N3O14, 728.3607).
Meehanine W (12): colorless, amorphous powder; [R]22D -13.0 (c
0.23, MeOH); CD (c 0.021, MeOH) λ(θ) 249 (2800), 224 (-29 300),
1
204 (8300) nm; H and 13C NMR, Tables 1 and 2; HRFABMS m/z
798.4031 [M + H]+ (calcd for C38H60N3O15, 798.4026).
Acid Hydrolysis of 3 and 4 and Determination of the Configu-
ration of 2-Methylbutyric Acid. Compounds 3 (1 mg) and 4 (0.5 mg)
were separately dissolved in 7% HCl (1 mL) and stirred for 1 h at
60 °C. After cooling, the solution was extracted with CH2Cl2 (2 × 3
mL). From the CH2Cl2 layer, 2-methylbutyric acid was obtained. The
CH2Cl2 layers were washed with H2O and dried over 3 Å molecular
sieves. To the solutions, 1-hydroxybenzotriazole monohydrate, N,N′,-
dicyclohexylcarbodiimide, and (S)-1-(1-naphthyl)ethylamine were added
(10 mg each). After the mixtures had been stirred for 3 h at room
temperature, filtration and concentration gave residues that were
analyzed by HPLC with detection at 280 nm. Analytical HPLC was
performed on a Shiseido Capcell pak C18 column (4.6 × 250 mm) at
20 °C using MeCN-H2O (40:60) as the solvent. Peaks were detected
with a Tosoh UV8010 UV detector. (S)-2-Methyl-N-[(S)-1-(1-naphth-
yl)ethyl]butyramide (tR 33.0 min) was identified as the product resulting
from the 2-methylbutyryl moiety of 3 and 4 by comparing their retention
times with those of the authentic samples, (S)-2-methyl-N-[(S)-1-(1-
naphthyl)ethyl]butyramide (tR 33.0 min) and (R)-2-methyl-N-[(S)-1-
(1-naphthyl)ethyl]butyramide (tR 34.4 min).1,10,11
The dried and powdered whole plants (670 g) of M. urticifolia were
extracted with 80% acetone (2 × 12 L) at 56 °C. The extract was
concentrated at reduced pressure, suspended in H2O (1.0 L), and
partitioned with Et2O (3 × 1.0 L). The H2O layer (53.1 g) was passed
through a Diaion HP-20 column (eluted with H2O, 10% and 90%
MeOH, and MeOH). The 90% MeOH eluate (12.9 g) was chromato-
graphed on an ODS column and eluted with 20%, 30%, 40%, 50%,
and 80% MeOH (fractions 2A-2E). Fraction 2C (1.06 g) was subjected
to preparative LPLC [column, Yamazen, Ultra Pack ODS-SM-50C-
M, 37 × 100 mm; solvent, MeOH-0.2% TFA (35:65)] to give 10
fractions (3A-3J). Fractions 3B and 3C (44.2 mg) were subjected to
preparative HPLC [columns, Shiseido, Capcell-Pak Ph, 20 × 250 mm;
solvent, MeCN-0.2% TFA (15:85), and YMC, ODS-AM, 10 × 300
mm; solvent, MeCN-H2O (25:75 or 20:80)] to yield compounds 1
(15.2 mg), 2 (5.5 mg), 3 (4.0 mg), 8 (0.6 mg), 9 (1.0 mg), 10 (0.9 mg),
and 12 (2.9 mg). Fractions 2A and 2B (10.3 g) were dissolved in H2O,
which was passed through a Diaion HP-20 column (eluted with 5%,
20%, and 50% MeOH, and MeOH), and the 50% MeOH eluate was
subjected to preparative LPLC [solvent, MeOH-0.2% TFA (35:65)]
to give nine fractions (4A-4I). Fractions 4B and 4C (185.7 mg) were
subjected to preparative HPLC [columns, Cosmosil, AR-II, 20 × 250
mm; solvent, MeCN-0.2% TFA (15:85), and ODS-AM, solvent,
MeCN-H2O (22:78)] to yield compounds 4 (1.8 mg), 11 (1.3 mg),
and 12 (0.8 mg).
Acid Hydrolysis of Compounds 1-12. Compounds 1-12 (0.5 mg
each) were separately stirred for 1 h at 60 °C in 7% HCl (2 mL). After
cooling, the reaction mixtures of compounds 1-4 and 10-12 were passed
through an Amberlite IRA400 column, and the eluates were subjected to
preparative HPLC [column, YMC Pack, ODS-AM, 10 × 300 mm; solvent,
MeOH-H2O (10:90); detector, UV 210 nm] to yield a sugar fraction. The
reaction mixtures of compounds 5-9 were subjected to preparative HPLC
[column, Kanto Chemical, Mightysil RP-18 GP, 10 × 250 mm; solvent,
MeOH-H2O (20:80); detector, UV 210 nm] to yield the (S)-(4-hydrox-
yphenyl)-8-(R)-O-hydroxy-10-N-[(S)-2-methylbutyl]amidated-1,5,10-triaza-
cyclotridecan-2-one and sugar fractions.
Meehanine L (1): colorless, amorphous powder; [R]23 -26.4 (c
D
0.66, MeOH); CD (c 0.066, MeOH) λ(θ) 236 (4100), 223 (-14 900),
216 (-11 300), 201 (-36 400) nm; 1H and 13C NMR, Tables 1 and 2;
HRFABMS m/z 762.3449 [M + H]+ (calcd for C37H52N3O14, 762.3451).
Meehanine M (2): colorless, amorphous powder; [R]22 -25.8 (c
Sugar Identification. Sugar fractions from the hydrolysis of
compounds 1-12 were dissolved in pyridine (0.5 mL each) and stirred
D
0.48, MeOH); CD (c 0.053, MeOH) λ(θ) 236 (3300), 223 (-13 700),